APDN to Participate in H.C. Wainwright BIOCONNECT 2021 Conference
January 5th, 2021
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Category: Press Release
Applied DNA Announces Preliminary Estimated First Fiscal Quarter 2021 Revenues in the Range of $1.3 Million to $1.6 Million
January 4th, 2021
APDN, CLEARED4 Partner on COVID-19 Testing Program
December 29th, 2020
FY’20 Year End and Q4 Financial Results
December 17th, 2020
APDN Awarded Pooled Surveillance Testing Contract Valued at Up to $2M
December 17th, 2020
NY Winter COVID-19 Plan Drives Demand for Applied DNA’s Pooled Surveillance Testing Program
December 11th, 2020
Applied DNA Schedules Fiscal 2020 Fourth Quarter Financial Results Conference Call for Thursday, December 17, 2020 at 4:30 PM EST
December 8th, 2020
Nutrition21 Transitions to CertainT® Platform to Secure Portfolio of Dietary Supplement Ingredients
December 7th, 2020
Applied DNA to Provide COVID-19 Surveillance Testing to Stony Brook Basketball
December 1st, 2020